共 50 条
- [21] Re: Siobhan P. Lynch, Yu Shen, Ashish Kamat, et al. Neoadjuvant Chemotherapy in Small Cell Urothelial Cancer Improves Pathologic Downstaging and Long-term Outcomes: Results from a Retrospective Study at the MD Anderson Cancer Center. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.04.020 [J]. EUROPEAN UROLOGY, 2012, 62 (03) : E65 - E66
- [22] Reply to Mengda Zhang and Long Wang's Letter to the Editor re: Francesco Porpiglia, Enrico Checcucci, Daniele Amparore, et al. Three-dimensional Augmented Reality Robot-assisted Partial Nephrectomy in Case of Complex Tumours (PADUA ≥ 10): A New Intraoperative Tool Overcoming the Ultrasound Guidance. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2019.11.024 [J]. EUROPEAN UROLOGY, 2020, 77 (06) : E163 - E164
- [23] Reply to Urmila Dhakad and Bhupendra Pal Singh's Letter to the Editor re: Dean A. Tripp, J. Curtis Nickel, Jennifer Wong, et al. Mapping of Pain Phenotypes in Female Patients with Bladder Pain Syndrome/Interstitial Cystitis and Controls. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.05.023 [J]. EUROPEAN UROLOGY, 2012, 62 (04) : E74 - E74
- [24] Reply to Gianluca Giannarini, Nazareno Suardi and Alberto Briganti's Letter to the Editor re: Prasanna Sooriakumaran, Abhishek Srivastava, Shahrokh F. Shariat, et al. A Multinational, Multi-institutional Study Comparing Positive Surgical Margin Rates Among 22 393 Open, Laparoscopic, and Robot-assisted Radical Prostatectomy Patients. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.11.018 [J]. EUROPEAN UROLOGY, 2014, 65 (06) : E91 - E92
- [25] Re: Jan P. Radtke, Constantin Schwab, Maya B. Wolf, et al. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.12.052 [J]. EUROPEAN UROLOGY, 2016, 70 (03) : E77 - E78
- [26] Re: Michal Sarfaty, Moshe Leshno, Noa Gordon, et al. Cost Effectiveness of Nivolumab in Advanced Renal Cell Carcinoma. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2017.07.041 Second-line Treatment in Metastatic Renal Cell Carcinoma. Can Immunotherapy Be Considered a Cost-effective Treatment? [J]. EUROPEAN UROLOGY, 2018, 73 (03) : E74 - E74
- [27] Reply to Henk G. van der Poel, Tessa Buckle and Renato Valdes Olmos' Letter to the Editor re: Steven Joniau, Laura Van den Bergh, Evelyne Lerut, et al. Mapping of Pelvic Lymph Node Metastases in Prostate Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.06.057 [J]. EUROPEAN UROLOGY, 2013, 63 (02) : E21 - E22
- [28] Re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014 [J]. EUROPEAN UROLOGY, 2015, 68 (02) : E31 - E32
- [29] Reply to Bhupendra Pal Singh and Urmila Dhakad's Letter to the Editor re: Beat Roth, Frederic D. Birkhauser, Pascal Zehnder, et al. Parenteral Nutrition Does Not Improve Postoperative Recovery from Radical Cystectomy: Results of a Prospective Randomised Trial. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.05.052 [J]. EUROPEAN UROLOGY, 2012, 62 (04) : E80 - E80
- [30] Reply to Hiten D. Patel and Mohamad E. Allaf's Letter to the Editor re: Maxine Sun, Andreas Becker, Zhe Tian, et al. Management of Localized Kidney Cancer: Calculating Cancer-specific Mortality and Competing Risks of Death for Surgery and Nonsurgical Management. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.03.034 [J]. EUROPEAN UROLOGY, 2013, 64 (05) : E107 - E108